Results 191 to 200 of about 24,289 (229)

Polymyxin resistance in Enterobacterales: overview and epidemiology in the Americas

International Journal of Antimicrobial Agents, 2021
The worldwide spread of carbapenem- and polymyxin-resistant Enterobacterales represents an urgent public-health threat. However, for most countries in the Americas, the available data are limited, although Latin America has been suggested as a silent spreading reservoir for isolates carrying plasmid-mediated polymyxin resistance mechanisms.
J. Rodríguez-Santiago, P. Cornejo-Juárez, J. Silva-Sánchez, U. Garza-Ramos   +3 more
openaire   +2 more sources

Socioeconomic disparities in the prevalence of multidrug resistance in Enterobacterales

Infection Control & Hospital Epidemiology, 2023
AbstractWe examined the association between multidrug resistance and socioeconomic status (SES), analyzing microbiological and ZIP-code–level socioeconomic data. Using generalized linear models, we determined that multidrug resistance is significantly and persistently more prevalent in samples taken from patients residing in low-income ZIP codes versus
Dylan R. Brown, Heather I. Henderson, Laura Ruegsegger, James Moody, David van Duin   +4 more
openaire   +2 more sources

Carbapenemase-Producing Enterobacterales in Algeria: A Systematic Review

Microbial Drug Resistance, 2020
The dramatic increase in prevalence and clinical impact of infections caused by carbapenemase-producing Enterobacterales (CPE) are major and ongoing public health problems globally. The carbapenemase groups most commonly encountered include Klebsiella pneumoniae carbapenemase (KPC), New Delhi
Mairi Assia, Abdelaziz Touati
exaly   +3 more sources

Trends in Enterobacterales Bloodstream Infections in Children

Pediatrics
OBJECTIVES Enterobacterales bloodstream infections (E-BSI) cause a significant burden of disease in children and are associated with antimicrobial resistance. We assessed temporal changes in the population-based incidence of E-BSI in children in Queensland, Australia.
Gibbs, Anna A.M., Laupland, Kevin B., Edwards, Felicity, Ling, Weiping, Channon-Wells, Samuel, Harley, David, Falster, Kathleen, Paterson, David L., Harris, Patrick N.A., Irwin, Adam D.   +9 more
openaire   +5 more sources

Rapid ResaCeftazidime-Avibactam Enterobacterales NP Test: Rapid Detection of Ceftazidime-Avibactam Susceptibility in Enterobacterales

Journal of Clinical Microbiology, 2022
Ceftazidime-avibactam (CZA), a novel β-lactam/β-lactamase inhibitor combination, has good antibacterial activity against carbapenem-resistant Enterobacterales (CRE) producing class A and C and some class D carbapenemases, but in recent years, the emergence of CZA-resistant Enterobacterales ...
Luozhu Feng, Yining Zhao, Zhuocheng Yao, Xiaodong Zhang, Shufang Zheng, Lijiang Chen, Ying Zhang, Lingbo Wang, Tieli Zhou, Jianming Cao   +9 more
openaire   +2 more sources

Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales

Journal of Antimicrobial Chemotherapy
Abstract Background Use of anti-carbapenem-resistant Enterobacterales (anti-CRE) agents such as ceftazidime/avibactam has been associated with improved clinical outcome in cohorts that primarily include patients infected with CRE that are resistant to meropenem (MCRE).
Gregory Weston, Abhigya Giri, Lauren Komarow, Lizhao Ge, Keri R Baum, Erin Abbenante, Jason C Gallagher, Jesse T Jacob, Keith S Kaye, Angela C Kim, W Charles Huskins, Marcus Zervos, Erica Herc, Robin Patel, David Van Duin, Yohei Doi   +15 more
openaire   +2 more sources

Resistencia a colistina en enterobacterales

2022
ABSTRACT Antimicrobial resistance currently represents one of the main public health problems worldwide. In our country, most nosocomial infections are caused by germs resistant to multiple antimicrobials. This situation has meant that in recent years colistin has been used for their treatment, the use of which has been limited for many years due to ...
openaire   +1 more source

Carbapenem-resistant Enterobacterales in the USA

The Lancet Infectious Diseases, 2020
Sumanth, Gandra, Carey-Ann D, Burnham
openaire   +2 more sources

Carbapenem-resistant Enterobacterales (CRE): The storm is coming

Intensive and Critical Care Nursing, 2023
Zahar, Jean-Ralph, Blot, Stijn
openaire   +4 more sources

Detection of carbapenemases in Enterobacterales susceptible in vitro to meropenem

Enfermedades Infecciosas y Microbiología Clínica
Carbapenemase-producing Enterobacterales (CPE) is a global threat. We evaluate the prevalence of CPE among isolates categorized as meropenem-susceptible, but that meet the European Committee on Antimicrobial Susceptibility Testing (EUCAST) screening cut-off values for carbapenemase detection, and analyze the susceptibility of these isolates to new ...
Luana Silva, Dornelles, Mariana Preussler, Mott, Gabriela, da Silva Collar, Luciana, Giordani, Rodrigo Minuto, Paiva, Larissa, Lutz   +5 more
openaire   +2 more sources